ArticleiScience2025

Maximizing survival benefit with precision therapy based on progressive patterns after immunochemotherapy in metastatic esophageal cancer.

Yingnan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.